title: Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
authors.affiliation: Service d'Hematologie, Hôtel Dieu, Paris, France.
authors.forename: R
authors.initials: R
authors.lastname: Zittoun
authors.forename: V
authors.initials: V
authors.lastname: Liso
authors.forename: F
authors.initials: F
authors.lastname: Mandelli
authors.forename: B
authors.initials: B
authors.lastname: Rotoli
authors.forename: T
authors.initials: T
authors.lastname: de Witte
authors.forename: C
authors.initials: C
authors.lastname: Gattringer
authors.forename: L
authors.initials: L
authors.lastname: Resegotti
authors.forename: F
authors.initials: F
authors.lastname: Caronia
authors.forename: P
authors.initials: P
authors.lastname: Leoni
authors.forename: M C
authors.initials: MC
authors.lastname: Petti
mesh_terms: D000206:Actuarial Analysis; D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D007558:Italy; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D012074:Remission Induction; D013866:Thioguanine / Q000008:administration & dosage
chemical_list: D000677:Amsacrine; D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin